GreggL.SemenzaMD
Pediatrics • Baltimore, MDProfessor of Pediatrics, Professor of Radiation Oncology and Molecular Radiation Sciences, Professor of Biological Chemistry, Professor of Medicine, Professor of Oncology, Johns Hopkins University School of Medicine; Director, Vascular Program, Institute for Cell Engineering
Are you Dr. Semenza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 N Caroline St
Baltimore, MD 21287Phone+1 410-955-3071
Summary
- Dr. Gregg Semenza, MD is a pediatrician in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and North Carolina. He is a Professor of Pediatrics at Professor of Biological Chemistry.
Education & Training
Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1990
Duke University HospitalResidency, Pediatrics, 1984 - 1986
Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
MD State Medical License 1990 - 2025
NC State Medical License 1984 - 1999- American Board of Medical Genetics and Genomics Clinical Genetics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Clinical Trials
- Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing Start of enrollment: 2006 Dec 01
Publications & Presentations
PubMed
- VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept.Deepti Sharma, Evan Lau, Yu Qin, Kathleen Jee, Murilo Rodrigues
Proceedings of the National Academy of Sciences of the United States of America. 2024-11-12 - 2 citationsHypoxia-inducible factor 1 recruits FACT and RNF20/40 to mediate histone ubiquitination and transcriptional activation of target genes.Yajing Lyu, Yongkang Yang, Varen Talwar, Haiquan Lu, Chelsey Chen
Cell Reports. 2024-04-23 - 14 citationsTargeting intratumoral hypoxia to enhance anti-tumor immunity.Gregg L Semenza
Seminars in Cancer Biology. 2023-11-01
Press Mentions
Researchers Identify Why Some Don’t Respond to Anti-VEGF Drugs for AMDNovember 13th, 2024- People of the U: Elizabeth WicksJanuary 18th, 2022
- 146th Annual Meeting of the American Neurological Association to Focus on Research and Development of Neurologic Disease TherapeuticsOctober 5th, 2021
- Join now to see all
